Allay Therapeutics, Inc. — Form D/A

Allay Therapeutics, Inc. of SAN JOSE, CA, a company, filed a Form D amendment with the SEC on 2023-12-21. The offering totals $86.9M, of which $86.9M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (29)

Showing 25 of 29 people.

NameRoleLocation
Tak A CheungDirectorSan Jose, CA
Josh A MakowerDirectorSan Jose, CA
Josh J MakowerDirectorValencia, CA
Michael A CarusiDirectorMenlo Park, CA
Leighton A ReadDirectorSan Jose, CA
Mark A DeemDirectorSan Jose, CA
Mark A DeemExecutive OfficerSan Jose, CA
Nicole A VitulloDirectorSan Jose, CA
Tiffany A LeDirectorSan Jose, CA
Adam A GridleyDirectorSan Jose, CA
Adam A GridleyExecutive OfficerSan Jose, CA
Paul A McCreadieDirectorSan Jose, CA
J.C. A LopezDirectorSan Jose, CA
Anselm A TanDirectorSan Jose, CA
Kristen A HowellsExecutive OfficerSan Jose, CA
Nicole J WalkerDirectorAnn Arbor, MI
Leighton J ReadDirectorMenlo Park, CA
Tak J CheungDirectorMenlo Park, CA
Adam J GridleyDirectorMenlo Park, CA
Adam J GridleyExecutive OfficerMenlo Park, CA
Paul J McCreadieDirectorMenlo Park, CA
Tak D CheungDirectorMenlo Park, CA
Josh D MakowerDirectorMenlo Park, CA
Leighton D ReadDirectorMenlo Park, CA
Adam D GridleyDirectorMenlo Park, CA

Other filings by this issuer (5)

FiledFormOfferingSold
2025-02-10D$60.0M$45.0M
2021-09-20D$82.4M$82.4M
2021-07-08D/A$18.0M$15.0M
2020-05-01D$15.0M$12.0M
2019-02-12D$28.8M$15.8M

More